Psychiatry and Psychiatrists – Page 2

Veterans and Lawmakers Lobby for Approval of MDMA Therapy

The F.D.A. is poised to rule on the therapeutic use of the club drug Ecstasy, a potential watershed moment in the nascent field of psychedelic medicine.

By Andrew Jacobs

American Psychiatric Assn Drug Abuse and Traffic Drugs (Pharmaceuticals) Ecstasy (Drug) Food and Drug Administration Institute for Clinical and Economic Review Justice Department Lykos Therapeutics Medicine and Health Mental Health and Disorders Multidisciplinary Assn for Psychedelic Studies Placebos Post-Traumatic Stress Disorder Psychedelic and Hallucinogenic Drugs Psychiatry and Psychiatrists Regulation and Deregulation of Industry Therapy and Rehabilitation Veterans your-feed-healthcare

FDA Panel Rejects Use of MDMA for Treatment of PTSD

An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.

By Andrew Jacobs

Harvard Medical School Harvard University Medicine and Health Mental Health and Disorders Psychiatry and Psychiatrists Research Social Media TikTok (ByteDance)

Harvard Cozies Up to #MentalHealth TikTok

As young Americans turn to TikTok for information on mental health, the T.H. Chan School of Public Health at Harvard is building its own team of influencers.

By Ellen Barry

Drug Enforcement Administration Drugs (Pharmaceuticals) Ecstasy (Drug) Food and Drug Administration MAPS Public Benefit Corporation Post-Traumatic Stress Disorder Psychiatry and Psychiatrists Research Therapy and Rehabilitation

MDMA Therapy for PTSD Inches Closer to U.S. Approval

Results of a new study may offer regulators enough evidence to allow the psychedelic, also known as Ecstasy, to be considered for use as a PTSD treatment.

By Rachel Nuwer

mosaec